Z-0217-2024 Class II

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-0217-2024 was initiated by Medtronic Neuromodulation on May 27, 2022 and is designated Class II. Reason for recall: There are a small number of units of the DBS Lead with StimLoc kit (3387S-40) due to a discrepancy in the Use By Date (UBD) printed on the outer packaged kit label versus the UBD printed on the… Affected quantity: 14 units.

Recall Details

Product Type
Devices
Report Date
Nov 8, 2023
Initiation Date
May 27, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14 units

Product Description

LEAD 3387S-40 STIMLOC DBS, Model Number 3387S-40. Electrical implantable device.

Reason for Recall

There are a small number of units of the DBS Lead with StimLoc kit (3387S-40) due to a discrepancy in the Use By Date (UBD) printed on the outer packaged kit label versus the UBD printed on the individual product label.

Distribution Pattern

US: MO, FL, TX, WA

Code Information

UDI/DI 00763000274320, Serial Number VA2JV2V

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0217-2024
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.